Skip to Content

Del. Code Ann. tit. 16, § 5176 - Waiver of informed consent requirement

Link to the law
This will open in a new window

The informed consent requirement for patients to participate in pharmaceutical research may be waived under certain conditions.  These include an unsuccessful attempt to secure the patient’s informed consent; the patient had not responded to accepted pharmaceutical therapies; the Institutional Review Board has approved the proposed waiver; the patient’s legal guardian or next of kin has provided consent on the waiver; and the waiver has been approved by the Superior Court.


Current as of June 2015